Key result
PVI plus CFAE and linear ablation was associated with higher freedom from atrial arrhythmia at one year compared to PVI alone (HR 1.56; 95% CI 1.04-2.34; p=0.032).
Why the study?
Does the addition of complex fractionated electrogram (CFAE) and/or linear ablation to pulmonary vein isolation (PVI) improve freedom from atrial arrhythmia in patients with persistent atrial fibrillation?
Observational (n=286)
Does the addition of complex fractionated electrogram (CFAE) and/or linear ablation to pulmonary vein isolation (PVI) improve freedom from atrial arrhythmia in patients with persistent atrial fibrillation?
Hazard Ratio: 1.56 (95% CI 1.04–2.34)
p-value: p=0.032
In patients with long-standing persistent AF (>30 months), adding CFAE ablation to PVI improves 1-year freedom from atrial arrhythmia, whereas adding linear ablation alone increases the risk of atrial tachycardia without improving outcomes.
Substrate ablation was associated with greater arrhythmia freedom in long-standing persistent AF; hypothesis-generating and requires randomized confirmation before practice change.
AIM: There is controversy and sparse data on whether substrate based techniques in addition to pulmonary vein isolation (PVI) confer benefit in the catheter ablation of persistent atrial fibrillation (AF), especially if long standing. We performed an observational study to assess whether substrate based ablation improved freedom from atrial arrhythmia. METHODS: A total of 286 patients undergoing first ablation procedures for persistent AF with PVI only(n = 79), PVI plus linear ablation(n = 85), or PVI plus complex fractionated electrogram (CFAE) and linear ablation(n = 107) were followed. Primary end point was freedom from atrial arrhythmia at one year. RESULTS: Mean duration of pre-procedure time in AF was 28+/-27 months.There were no differences in baseline characteristics between groups except a higher proportion of patients with a severely dilated LA in those receiving PVI+CFAEs+lines. Freedom from atrial arrhythmia was higher with a PVI+CFAE+lines strategy then for PVI alone (HR 1.56, 95% CI: 1.04-2.34, p=0.032) but was not higher with PVI+lines. Benefit of substrate modification was conferred for preprocedure times in AF of over 30 months. The occurrence of atrial tachycardia was higher when lines were added to the ablation strategy (HR 0.08, 95% CI: 0.01-0.59, p=0.014). Freedom from atrial arrhythmia at 1 year was higher with lower patient age, use of general anaesthetic (GA), normal or mildly dilated left atrium and decreasing time in AF. CONCLUSIONS: In patients with long standing persistent AF of over 30 months duration,CFAE ablation resulted in improved freedom from atrial arrhythmia. Increased freedom from atrial arrhythmia occurs in patients who are younger and have smaller atria, and with GA procedures. Linear ablation did not improve outcome and resulted in a higher incidence of atrial tachycardia.
No takes yet. Share an insight, caveat, or question.
Martin Claire A (2017) conducted an observational in persistent atrial fibrillation (n=286). PVI plus complex fractionated electrogram (CFAE) and linear ablation vs. PVI alone was evaluated on freedom from atrial arrhythmia at one year (HR 1.56, 95% CI 1.04-2.34, p=0.032). PVI plus CFAE and linear ablation was associated with higher freedom from atrial arrhythmia at one year compared to PVI alone (HR 1.56; 95% CI 1.04-2.34; p=0.032).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: